Galectin Therapeutics Inc... (GALT)
NASDAQ: GALT
· Real-Time Price · USD
3.57
-0.19 (-5.05%)
At close: Aug 15, 2025, 3:59 PM
3.55
-0.56%
After-hours: Aug 15, 2025, 06:50 PM EDT
Galectin Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -2 | -1.69 | -3.82 | -2.96 | -3.29 | -2.5 | -2.75 | -2.35 | -2.71 | -1.58 | -2.82 | -2.02 | -2.41 | -4.19 | -6.75 | -5.52 | -4.89 |
PEG Ratio | 0.10 | -0.3 | 0.38 | -0.56 | -0.18 | 0.07 | -0.05 | 0.11 | 0.04 | -0.01 | 0.23 | 0.34 | -0.06 | 0.29 | 1.01 | -0.15 | 0.23 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 1.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -0.69 | -0.79 | -1.85 | -1.78 | -2.13 | -1.66 | -2.25 | -1.68 | -2.93 | -2.09 | -4.33 | -5.11 | -15.43 | 46.31 | 24.87 | 10.90 | 6.80 |
P/FCF Ratio | -10.03 | -6.33 | -20.06 | -17.55 | -12.49 | -21.24 | -15.01 | -8.73 | -11.57 | -9.28 | -11.6 | -10.47 | -11.88 | -17.43 | -46.03 | -31.22 | -19.43 |
P/OCF Ratio | -10.03 | -6.33 | -20.06 | -17.55 | -12.49 | -21.24 | -15.01 | -8.73 | -11.57 | -9.28 | -11.6 | -10.47 | -11.88 | -17.43 | -46.03 | -31.22 | -19.43 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -58.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.96 | -1.03 | -1.13 | -1.14 | -1.16 | -1.19 | -1.2 | -1.18 | -1.17 | -1.24 | -1.34 | -1.95 | -4.73 | 11.11 | 2.09 | 0.57 | 0.00 |
Quick Ratio | 0.08 | 0.49 | 1.13 | 1.87 | 2.02 | 1.77 | 2.05 | 1.96 | 1.70 | 1.58 | 1.79 | 2.37 | 3.51 | 4.63 | 4.58 | 5.51 | 4.89 |
Current Ratio | 0.08 | 0.49 | 1.13 | 1.87 | 2.02 | 1.77 | 2.05 | 1.96 | 1.70 | 1.58 | 1.79 | 2.37 | 3.51 | 4.63 | 4.58 | 5.51 | 4.89 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -7.2 | -6.07 | -8.9 | -9.17 | -11.29 | -10.98 | -13.85 | -22.48 | -34.52 | -30.19 | -42.19 | -43.77 | -27.3 | -74.27 | -96.39 | -287.14 |
Return on Equity | 0.09 | 0.12 | 0.12 | 0.15 | 0.16 | 0.17 | 0.20 | 0.18 | 0.27 | 0.33 | 0.38 | 0.63 | 1.60 | -2.76 | -0.92 | -0.49 | -0.35 |
Return on Assets | -1.01 | -0.68 | -0.39 | -0.45 | -0.44 | -0.35 | -0.47 | -0.45 | -0.57 | -0.5 | -0.48 | -0.37 | -0.3 | -0.17 | -0.22 | -0.25 | -0.28 |
Return on Invested Capital | n/a | -3.86 | -0.64 | -0.86 | -0.73 | -0.76 | -0.78 | -0.89 | -1.18 | -1.28 | -0.97 | -0.64 | -0.41 | -0.23 | -0.28 | -0.3 | -0.35 |
Dividend Yield | 0.00 | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 |
Payout Ratio | -0.01 | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | -0.00 | n/a | n/a | n/a | -0.01 |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.89 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -124.96 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -124.96 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -119.51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -114.26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |